The Biomedical Research Centre, University of British Columbia, Room #401, 2222 Health Sciences Mall, Vancouver, BC, V6T1Z3 Canada.
Expert Rev Proteomics. 2012 Jun;9(3):281-91. doi: 10.1586/epr.12.22.
Despite the rapid growth of postgenomic data and fast-paced technology advancement, drug discovery is still a lengthy and difficult process. More effective drug design requires a better understanding of the interaction between drug candidates and their targets/off-targets in various situations. The ability of chemical proteomics to integrate a multiplicity of disciplines enables the direct analysis of protein activities on a proteome-wide scale, which has enormous potential to facilitate drug target elucidation and lead drug verification. Over recent years, chemical proteomics has experienced rapid growth and provided a valuable method for drug target identification and inhibitor discovery. This review introduces basic concepts and technologies of different popular chemical proteomic approaches. It also covers the essential features and recent advances of each approach while underscoring their potentials in drug discovery and development.
尽管后基因组数据快速增长,技术也快速进步,但药物发现仍然是一个漫长而困难的过程。更有效的药物设计需要更好地了解候选药物及其在各种情况下的靶点/非靶点之间的相互作用。化学蛋白质组学将多个学科整合在一起的能力,使我们能够直接在蛋白质组范围内分析蛋白质的活性,这对于促进药物靶点阐明和先导药物验证具有巨大的潜力。近年来,化学蛋白质组学发展迅速,为药物靶点鉴定和抑制剂发现提供了一种有价值的方法。本文介绍了不同流行的化学蛋白质组学方法的基本概念和技术。它还涵盖了每种方法的基本特征和最新进展,同时强调了它们在药物发现和开发中的潜力。